تخطي إلى التنقل الرئيسي
تخطي إلى البحث
تخطي إلى المحتوى الرئيسي
الصفحة الرئيسية
المساعدة والأسئلة الشائعة
English
עברית
العربية
الصفحة الرئيسية
الملفات الشخصية
الوحدات البحثية
نتاج البحث
الجوائز
أنشطة
البحث حسب الخبرة أو الاسم أو الانتماء
عرض الملف الشخصي الخاص بـ Scopus
נעמי רחימי לוין
Dr.
Senior Lecturer / Assistant Professor
,
Department of Medicine
https://orcid.org/0000-0003-3411-886X
1994 …
2025
نتاج الأبحاث سنويًا
معاينة
بصمة
الشبكة
نتاج البحث
(74)
ملفات شخصية مماثلة
(6)
بصمة
تأتي تسميات الموضوعات هذه من أعمال هذا الشخص. فهما يشكلان معًا بصمة فريدة.
فرز حسب
الوزن
أبجديًا
Keyphrases
Chronic Lymphocytic Leukemia
100%
COVID-19
54%
Israeli
47%
Convalescent Plasma
35%
Israel
32%
Fludarabine
31%
Rituximab
30%
Cyclophosphamide
26%
Transfusion
24%
COVID-19 Pandemic
24%
Blood Transfusion
24%
COVID-19 Patients
22%
Chemotherapy
18%
Leukemia Patients
16%
Prognostic Significance
15%
BNT162b2 Vaccine
15%
Immunoglobulin
14%
Transfusion Trigger
14%
Transfusion Medicine
14%
Rituximab Therapy
13%
Multivariate Analysis
12%
Richter Transformation
12%
Haemoglobin Trigger
12%
Richter Syndrome
12%
Group Experiences
12%
Medical Education
12%
Electronic Learning
12%
Hematological Malignancies
12%
Blood Bank
12%
Clinical Trials
12%
Blood Loss
12%
Radical Retropubic Prostatectomy
12%
Protein Z
12%
Vaccination
12%
Convalescent
12%
Overall Survival
12%
Red Blood Cell Transfusion
10%
Home Transfusion
10%
Oncology Patients
10%
Elderly Patients
10%
Clinical Data
10%
Internal Medicine Wards
9%
Severe COVID-19
9%
Prognostic Marker
9%
In-hospital Mortality
9%
Polycythemia Vera
9%
Titer
9%
Transplantation
9%
Convalescent Plasma Therapy
9%
Low Protein
9%
Medicine and Dentistry
COVID-19
64%
B-Cell Chronic Lymphocytic Leukemia
58%
Blood Transfusion
29%
Erythrocyte
26%
Retrospective Study
25%
Lymphocyte
19%
Prevalence
18%
Rituximab
18%
Polycythemia vera
18%
Diseases
16%
Overall Survival
15%
Coronavirinae
15%
Infection
15%
Bleeding
14%
Richter's Transformation
12%
Radical Retropubic Prostatectomy
12%
Protein Z
12%
Convalescence
12%
Diffuse Large B-Cell Lymphoma
10%
Multivariate Analysis
10%
Pandemic
9%
Multiple Myeloma
8%
Internal Medicine
8%
Immunoglobulin
8%
Blood Clotting
8%
Erythrocyte Transfusion
7%
Transfusion Medicine
7%
Anemia
7%
Receptor
7%
Interleukin 6
6%
Thrombocytopenia
6%
Interleukin 2 Receptor Alpha
6%
Membrane Antigen
6%
Autosomal Dominant Inheritance
6%
Biological Marker
6%
Blood Group ABO System
6%
Rebound
6%
Myelofibrosis
6%
Alloimmunization
6%
Plasmacytoma
6%
Myeloproliferative Neoplasm
6%
Heart Disease
6%
Mass Casualty
6%
Thrombocytosis
6%
Thymus
6%
Central Retinal Artery Occlusion
6%
Central Retinal Vein Occlusion
6%
Insect Bite
6%
Thrombotic Thrombocytopenic Purpura
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
69%
Diseases
36%
Infection
33%
Fludarabine
31%
Rituximab
31%
Cyclophosphamide
26%
Prevalence
16%
Coronavirinae
15%
Hospital Mortality
12%
Clinical Trial
12%
Hematologic Malignancy
12%
Polycythemia vera
12%
Immunoglobulin
12%
Overall Survival
11%
Pandemic
10%
Multiple Myeloma
10%
Interleukin 6
9%
Chemotherapy
9%
Cohort Study
8%
SARS Coronavirus
7%
Retrospective Study
6%
Monotherapy
6%
Disease Severity
6%
Plasmacytoma
6%
Neutralizing Antibody
6%
Convalescence
6%
Statin (Protein)
6%
Fatty Acid
6%
Alloantibody
6%
Cytokine
6%
Blood Clotting Factor 7 Deficiency
6%
Myelofibrosis
6%
Immunoglobulin G Antibody
6%
Insect Bite
6%
Complement Component C5a
6%
Thrombotic Thrombocytopenic Purpura
6%
Syndrome
6%
COVID-19 Vaccine
6%
Thromboplastin
6%
Cytopenia
6%
Antiphospholipid Antibody
6%
Prothrombin
6%
Hemolytic Anemia
6%
Rare Disease
6%
Elotuzumab
6%
Lenalidomide
6%
Dexamethasone
6%
Adult Respiratory Distress Syndrome
6%
Iron
6%
Severe Acute Respiratory Syndrome
5%
